Literature DB >> 9368659

Recommendations for the biopsy procedure and assessment of skeletal muscle biopsies.

J R Anderson1.   

Abstract

Muscle biopsy has a valuable diagnostic role in many neuromuscular diseases, but it is an invasive investigation that should not be undertaken lightly. Furthermore, the biopsy procedure and subsequent laboratory processing of the specimen may significantly influence the results. The following guide is designed to optimise the diagnostic information that can be obtained from muscle biopsy. It covers the whole procedure, from selection of the biopsy site and technique of biopsy, progressing through freezing of the specimen for histochemistry, and the role of immunocytochemistry and electron microscopy. Finally, the contents of a model biopsy report are considered.

Entities:  

Mesh:

Year:  1997        PMID: 9368659     DOI: 10.1007/s004280050093

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  4 in total

1.  Optimal Immunofluorescent Staining for Human Factor IX and Infiltrating T Cells following Gene Therapy for Hemophilia B.

Authors:  Geoffrey L Rogers; Brad E Hoffman
Journal:  J Genet Syndr Gene Ther       Date:  2012-08-15

2.  Human Vastus Lateralis Skeletal Muscle Biopsy Using the Weil-Blakesley Conchotome.

Authors:  Alicja M Baczynska; Sarah Shaw; Helen C Roberts; Cyrus Cooper; Avan Aihie Sayer; Harnish P Patel
Journal:  J Vis Exp       Date:  2016-03-04       Impact factor: 1.355

3.  Routinely frozen biopsies of human skeletal muscle are suitable for morphological and immunocytochemical analyses at transmission electron microscopy.

Authors:  M Giagnacovo; R Cardani; G Meola; C Pellicciari; M Malatesta
Journal:  Eur J Histochem       Date:  2010-07-08       Impact factor: 3.188

4.  Muscle biopsies in children--an evaluation of histopathology and clinical value during a 5-year period.

Authors:  Marius Kurås Skram; Sasha Gulati; Erik Larsson; Sigurd Lindal; Sverre Helge Torp
Journal:  Ups J Med Sci       Date:  2009       Impact factor: 2.384

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.